Tumour-cell specific gene expression and its use in cancer therapy

Details for Australian Patent Application No. 2001279679 (hide)

Owner Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research

Inventors Krek, Wilhelm; Imbert, Georges; Gallani, Anne-Isabelle

Agent Davies Collison Cave

Pub. Number AU-B-2001279679

PCT Pub. Number WO01/98511

Priority 0015371 23.06.00 GB

Filing date 21 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 21 April 2005

International Classifications

C12N 015/85 Mutation or genetic engineering - for animal cells

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 038/17 Medicinal preparations containing peptides - from animals

Event Publications

21 April 2005 Application Accepted

  Published as AU-B-2001279679

18 August 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001279680

2001279678-Differential diagnosis of neurological diseases